Uniplan Investment Counsel, Inc. Merck & Co., Inc. Transaction History

Uniplan Investment Counsel, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $3.27 Million - $3.66 Million	-44,453 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $3.21 Million - $4.02 Million	44,453 New	44,453 $3.41 Million
Q1 2018 May 14, 2018	SELL	$50.96 - $59.23 $10.6 Million - $12.4 Million	-208,915 Closed	0 $0
Q4 2017 Feb 13, 2018	SELL	$51.62 - $61.64 $852,091 - $1.02 Million	-16,507 Reduced 7.32%	208,915 $11.8 Million
Q3 2017 Nov 14, 2017	BUY	$58.67 - $63.13 $13.2 Million - $14.2 Million	225,422	225,422 $14.4 Million

3,820

1.88B

15.6M

13.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $251B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Uniplan Investment Counsel, Inc., based on Form 13F filings with the SEC.

Stay updated on Uniplan Investment Counsel, Inc. with notifications on news.